Experts advising the U.S. government recommend a third dose for children ages 5 to 11.
At a time when coronavirus cases are on the rise, a committee of experts advising the U.S. government has recommended that “children ages 5 to 11 should receive a booster dose of Pfizer vaccine against COVID-19 “.
The Centers for Disease Control and Prevention (CDC) quickly accepted the recommendation, opening up the possibility of applying a third injection of COVID-19 vaccine to healthy elementary school children, as already recommended for those over 12 years of age.
Additional injection is expected to strengthen protection for children aged 5 to 11, by the time infections rise again.
Earlier this week, the Food and Drug Administration (FDA) approved Pfizer’s infant booster vaccine, which will offer at least five months after the last injection For the kids.
The CDC takes the next step by recommending who really needs vaccinations.
Counselors debate whether all children ages 5 to 11, who are generally healthy, need an extra dose, especially since many of them became infected during the winter wave of the omicron variant.
Due to the increase in cases in the United States, they recommend a booster for children aged 5 to 11 years. Photo: REUTERS
However, the United States is reporting for the first time since February an average of 100 thousand new cases per day. And CDC advisers point to growing evidence to older children and adults that the two primary vaccines along with a booster provide greater protection against new coronavirus variants.
“Maybe it was always meant to be a three-dose vaccine,” Drs. Grace Lee of Stanford University, who chairs the CDC’s advisory panel.
The issue of booster shots is not the most serious issue: Parents are eagerly awaiting the opportunity to vaccinate children under 5 years old, the only group not yet qualified in the United States.
The FDA’s Dr. Doran Fink said the agency is working “as fast as we can” to review an application from drugmaker Moderna, while awaiting final results from rival Pfizer on the vaccine for younger children.
The WHO approved the single-dose Cansino vaccine against Covid
The World Health Organization on Thursday announced the emergency approval of the coronavirus vaccine by CanSino Biologics company Convidencia, as Beijing struggles with a resurgence of the pandemic.
This is the first anticovid serum approved by WHO this year, and thus joins a list that includes developments by Pfizer-BioNTech, Moderna, Johnson & Johnson, AstraZeneca, Bharat Biotech, Novavax and the aforementioned Sinovac and Sinopharm.
The Chinese vaccine is based on a modified human adenovirus, given in a single dose and recommended by the WHO for all age groups from 18 years of age, according to a WHO statement.
This serum achieves an effectiveness of 91.7% to prevent chronic cases of coronavirus, according to a phase 3 clinical study published this Wednesday in The Lancet magazine.
Doses of this vaccine have already been applied in Argentina. The Government even announced an agreement to buy millions of doses that would eventually lose weight. Those who receive it in the country are from hard -to -reach populations, that is, people living on the streets or from marginal neighborhoods, migrants, and so on.
With information from agencies
DD/GRB
Source: Clarin
